<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>brilabuskes</author_name><author_url>https://kffhealthnews.org/news/author/brilabuskes/</author_url><title>Sloan Kettering's Widening Institutional Reckoning Over Ethics Crisis Snags Center's Top Executive - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="piwi0hjtga"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/sloan-katterings-widening-institutional-reckoning-over-ethics-crisis-snags-centers-top-executive/"&gt;Sloan Kettering&#x2019;s Widening Institutional Reckoning Over Ethics Crisis Snags Center&#x2019;s Top Executive&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/sloan-katterings-widening-institutional-reckoning-over-ethics-crisis-snags-centers-top-executive/embed/#?secret=piwi0hjtga" width="600" height="338" title="&#x201C;Sloan Kettering&#x2019;s Widening Institutional Reckoning Over Ethics Crisis Snags Center&#x2019;s Top Executive&#x201D; &#x2014; KFF Health News" data-secret="piwi0hjtga" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>Memorial Sloan Kettering Cancer Center President, Dr. Craig Thompson, announced that he will resign from the boards of Merck and Charles River Laboratories. Merck is the maker of the blockbuster cancer treatment Keytruda. Memorial Sloan Kettering Cancer Center has been thrust under the microscope recently over controversy involving top officials' financial conflicts of interest.</description></oembed>
